Filter
709
Text search:
Georgia
Featured
Recommendations
60
New Publications
115
Language
Document type
No document type
440
Studies & Reports
121
Manuals
57
Guidelines
51
Fact sheets
13
Strategic & Response Plan
7
Training Material
6
Situation Updates
6
Resource Platforms
6
Online Courses
2
Countries / Regions
Western and Central Europe
58
Global
35
Eastern Europe
33
Ukraine
24
Georgia
18
Eastern Europe and Central Asia
11
Latin America and the Carribbean
10
Russia
10
Ethiopia
9
Germany
9
Kenya
8
India
7
Tajikistan
7
Asia
6
Africa
6
Sierra Leone
5
USA
5
Moldova
5
Liberia
4
Senegal
4
Congo, Democratic Republic of
4
Uganda
4
Somalia
4
South Sudan
4
Syria
4
Brazil
4
North Macedonia
4
Colombia
4
Armenia
4
Mozambique
3
Central African Republic
3
Argentina
3
Middle East and North Africa
3
Paraguay
3
Venezuela
3
Kyrgyzstan
3
Vietnam
3
Guinea
2
Nigeria
2
Morocco
2
Nepal
2
Pakistan
2
Jordan
2
Lebanon
2
Zambia
2
Turkey
2
Rwanda
2
Indonesia
2
South Africa
2
Namibia
2
Hungary
2
Mexico
2
Myanmar / Burma
2
West and Central Africa
2
Western Pacific Region
2
Poland
2
Romania
2
Iran
2
Uzbekistan
2
Kazakhstan
2
Portugal
2
Spain
2
Belarus
2
Saudi Arabia
1
Ghana
1
Iraq
1
Tanzania
1
Thailand
1
Malawi
1
Sudan
1
Benin
1
Serbia
1
Ecuador
1
Greece
1
Sri Lanka
1
Yemen
1
East and Southern Africa
1
South–East Asia Region
1
Italy
1
Albania
1
Laos
1
Jamaica
1
Belgium
1
France
1
Tunisia
1
United Kingdom
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
87
Clinical Guidelines
50
Public Health
42
Women & Child Health
35
Key Resources
29
Capacity Building
23
Pharmacy & Technologies
6
Toolboxes
HIV
125
TB
101
Mental Health
99
COVID-19
47
Disability
35
Rapid Response
27
Refugee
22
Conflict
20
Planetary Health
18
NTDs
17
Global Health Education
16
AMR
13
Ebola
11
NCDs
11
Natural Hazards
10
Pharmacy
9
Zika
8
Specific Hazards
8
Caregiver
8
Health Financing Toolbox
7
Polio
6
Social Ethics
3
Bull World Health Organ 2017;95:594–598
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Policy statement.
MMWR. Recommendations and Reports:
December 16, 2005 / 54(RR15);49-55
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.